Timing COX-2 Inhibition in Muscle Repair
2026-09-24
A time-resolved view of COX-2 signaling reveals why inhibitor effects in injured muscle can change from vascular protection to pro-repair remodeling. Learn how Lumiracoxib can help translational researchers test that biology with stronger controls and more informative endpoints.
Metabolic Sensitization of Ferroptosis and Cuproptosis
2026-09-23
The reference study introduces SCu/L, a copper-containing liposome system carrying STF-31 to inhibit glycolysis and compensatory NAD+ metabolism. By lowering ATP, NADPH, and glutathione-related defenses while limiting copper efflux, the strategy synchronously increases ferroptosis and cuproptosis and supports immunogenic tumor-cell death.
KPT-330 in TNBC: From Export Blockade to Assay Design
2026-09-22
KPT-330 (Selinexor) is examined here as a mechanistic tool for studying CRM1-dependent nuclear export in triple-negative breast cancer. This article connects combination-screening evidence with practical assay design, model selection, and interpretation of tumor response.
Taltirelin–TRHR Signaling and TH in Striatal Neurons
2026-09-22
Zhu et al. identify a previously underdefined mechanism by which Taltirelin induces tyrosine hydroxylase expression in striatal medium spiny neurons through a TRHR–MAPK–RARα–DRD2 signaling axis. The work connects transcriptomic, cellular, and behavioral analyses in a hemi-Parkinson’s disease model, while also clarifying why TH induction should not automatically be interpreted as complete dopaminergic neuron replacement.
Diclofenac in Human Intestinal Organoid Assays
2026-09-21
Diclofenac combines a defined cyclooxygenase mechanism with a practical route into human stem cell-derived intestinal models. This workflow connects cyclooxygenase inhibition assay readouts with epithelial pharmacokinetics, CYP activity, transporter function, and inflammation signaling pathway analysis.
Engage & Evasion Improves EV Therapy Distribution
2026-09-21
Liu et al. introduce a sequential extracellular vesicle strategy that first engages the mononuclear phagocyte system with CD47low vesicles and then protects therapeutic CD47high vesicles from rapid uptake. The study links this sequence to lower liver and spleen entrapment, higher circulating levels, and improved accumulation outside major phagocyte organs.
Lysis Buffer for Reliable Mouse Genotyping
2026-09-20
Build a faster, more reproducible mouse genotyping workflow with a lysis buffer designed for tail, toe, and ear tissue. This practical guide connects tissue processing, proteinase K digestion, DNA quality control, and downstream genetic analysis without overstating what a pre-analytic reagent can prove.
Potassium Iodide (KI): Research Workflows
2026-09-19
Use Potassium Iodide as a controlled iodide source for thyroid-focused experiments, solution preparation, and formulation controls—not as an unvalidated immunotherapy ingredient. This guide combines practical KI handling with assay-design lessons from an MMP-2-responsive liposomal immunotherapy study.
L. reuteri FN041 Remodels Colitis Microbiota
2026-09-19
This mouse study shows that human milk-derived Limosilactobacillus reuteri FN041 reduced DSS-associated colitis severity while improving barrier, inflammatory, microbial, and metabolic readouts. Its main innovation is an integrated microbiome–metabolome analysis that connects probiotic treatment with coordinated changes in gut bacteria and cecal metabolites, although causal mechanisms and clinical relevance remain to be established.
Shufeng Xingbi Therapy in Allergic Rhinitis Rats
2026-09-18
This preprint investigates how Shufeng Xingbi Therapy affects allergic-rhinitis symptoms, Th1/Th2-related signaling, and intestinal microbial composition in OVA-induced rats. Its integrated behavioral, histological, immunological, gene-expression, and 16S rDNA analysis suggests that treatment-associated microbiome changes and increased short-chain fatty acids may accompany reduced nasal inflammation, although causal and clinical conclusions remain limited.
Tetrahedral DNA Frameworks Improve EOS
2026-09-18
The reference study introduces tetrahedral DNA nanostructures as an ordered interface for improving enzyme access to surface-bound primers during enzymatic oligonucleotide synthesis. Its results link primer geometry with higher catalytic performance, fewer deletion errors, and successful synthesis of a 60-nucleotide information-bearing fragment.
Engineering Confidence in mRNA Delivery
2026-09-17
Translational mRNA research increasingly depends on separating delivery, intracellular trafficking, and productive translation rather than treating expression as a single endpoint. This thought-leadership article examines how dual-reporter design, Cap1 capping, 5-moUTP modification, and Cy5 labeling can strengthen delivery decisions while placing recent extrahepatic targeting advances in the right preclinical context.
DAPT (GSI-IX): From Notch to Organoids
2026-09-17
A translational framework for using DAPT (GSI-IX) to interrogate γ-secretase, Notch signaling, APP processing, and hepatobiliary organoid biology while separating mechanistic evidence from therapeutic inference.
KN-62 Maps CaMKII Control of Memory Signaling
2026-09-16
KN-62 is a selective CaMKII inhibitor that can help separate calcium-dependent kinase signaling from proteolytic mechanisms supporting social memory. This article connects KN-62 assay design with Neuroligin 1 cleavage, cofilin-dependent spine remodeling, metabolism, secretion, and cell-cycle analysis.
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-15
Use dual fluorescence to separate mRNA uptake from productive EGFP expression in nanoparticle validation, macrophage studies, and quantitative transfection screens. This workflow combines Cy5 trafficking data, functional translation readouts, and reference-informed formulation controls for faster troubleshooting.